I work in health policy at HHS in DC. Cornell AB/Harvard PhD but basically a Brooklynite. Tweets are my personal views and retweets do not imply endorsement.
My entire HHS/ASPE division (Health Care Financing Policy) was RIFed and I am looking for new opportunities to help improve U.S. health care, esp. re drug pricing. Please DM here or at https://t.co/YtjM1kzqOX.
New #OSPCORTF special Issue of @MedicalCare. Abstracts are invited on health equity data and research findings that advance the understanding of health equity in patient-centered outcomes research. Due July 1. See https://t.co/z3cqmvJrtm
New #OSPCORTF special Issue of @MedicalCare. Abstracts are invited on health equity data and research findings that advance the understanding of health equity in patient-centered outcomes research. Due July 1st. See https://t.co/eEtscxpOsO
The #InflationReductionAct is making improvements to #Medicare to increase accessibility & affordability of Rx drugs for about 53 million Part D enrollees.
Read more about Part D enrollees’ use & total out-of-pocket spending for selected 10 drugs ➡️➡️ https://t.co/lyQoLm3hbl
And here's a separate GS 12-13 Economist posting that closes 8/24. Be sure to submit transcript as per instructions to be considered for either position.
New ASPE Report: “Health Coverage Under the Affordable Care Act: Current Enrollment Trends and State Estimates” shows more than 40 million people are enrolled in Affordable Care Act Marketplaces or Medicaid expansion coverage, highest total on record. https://t.co/WpDqVuGNOq